Characterization of a Reproducible Rat Model of Hepatic Veno-occlusive Disease
Overview
Affiliations
Lack of a reproducible animal model has hampered progress in understanding hepatic veno-occlusive disease (HVOD). This article characterizes a reproducible model of HVOD. Rats gavaged with monocrotaline, 160 mg/kg, were killed between days 1 and 10. Sections were evaluated by light microscopy with a standardized scoring system, by immunoperoxidase staining with ED-1 (monocytes, macrophages) and ED-2 (Kupffer cells) antibodies, and by transmission (TEM) and scanning electron microscopy (SEM). On days 1 and 2, the earliest manifestations were progressive injury to the sinusoidal wall with loss of sinusoidal lining cells, sinusoidal hemorrhage, and mild damage to central vein (CV) endothelium. On days 3 through 5 ("early HVOD"), there was centrilobular coagulative necrosis, severe injury to sinusoids, severe sinusoidal hemorrhage, and severe CV endothelial damage; inflammation with ED-1-positive cells was most marked on these days. Days 6 and 7 ("late HVOD") were characterized by subendothelial and advential fibrosis of CVs, damage of the CV endothelium with subendothelial hemorrhage, and some restoration of the sinusoidal wall. Between days 8 and 10, sections showed interindividual variation ranging from mild, residual fibrosis to severe, late HVOD. From days 1 through 10, ED-2-positive cells were decreased in number, and the number of ED-1-positive cells was increased. Sinusoidal damage is the earliest change in HVOD. Coagulative necrosis follows sinusoidal injury and resolves with improvement in sinusoidal endothelial cell (SEC) morphology. Moderate-to-severe CV fibrosis occurs after reappearance of sinusoidal lining cells and resolution of hepatocyte necrosis. The inflammatory response within the lobule and CVs is a result of recruitment of monocytes, whereas Kupffer cells are decreased in number.
Sawyer J, Elliott T, Orton L, Sowell H, Gatwood K, Shultes K Clin Hematol Int. 2024; 6(2):1-10.
PMID: 38817311 PMC: 11087001. DOI: 10.46989/001c.94952.
Xiong A, Lu L, Jiang K, Wang X, Chen Y, Wang X Arch Toxicol. 2024; 98(8):2557-2576.
PMID: 38703205 DOI: 10.1007/s00204-024-03762-x.
Shu Y, Hu L, Yang L, Chu H, Ye J, Jin Y Curr Med Sci. 2023; 43(6):1183-1194.
PMID: 37950130 DOI: 10.1007/s11596-023-2801-y.
Rat Deconvolution as Knowledge Miner for Immune Cell Trafficking from Toxicogenomics Databases.
Morita K, Mizuno T, Azuma I, Suzuki Y, Kusuhara H Toxicol Sci. 2023; .
PMID: 37941435 PMC: 10823770. DOI: 10.1093/toxsci/kfad117.
Shang H, Huang C, Xiao Z, Yang P, Zhang S, Hou X Cell Biosci. 2023; 13(1):127.
PMID: 37422682 PMC: 10329330. DOI: 10.1186/s13578-023-01078-4.